fda ruling on tirzepatide today says shortage of GLP-1 drug is over Tirzepatide Wins FDA Approval for

Both routes are effective, though subcutaneous injection has become more popular due to ease and comfort

References Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK

10.1161/CIRCULATIONAHA.118.038868 60 ZhengS

Younger workers appeared especially influenced by access to these treatments when making career decisions

Clinical Uses: Nausea & vomiting (postoperative, drug-induced, migraine-associated) Diabetic gastroparesis Gastroesophageal reflux disease (GERD) Facilitation of small-bowel intubation Adverse Effects: Extrapyramidal symptoms (EPS) such as dystonia, tremors Drowsiness, restlessness Long-term use Tardive dyskinesia Contraindicated in Parkinsons disease & bowel obstruction Clinical Tip: Use short-term (12 weeks) when possible